Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
J Allergy Clin Immunol Pract. 2023 Sep;11(9):2830-2838.e4. doi: 10.1016/j.jaip.2023.04.044. Epub 2023 May 12.
The association between allergic diseases and the risk of mycobacterial disease is unclear.
To evaluate the association between allergic diseases and mycobacterial diseases.
This was a population-based cohort study of 3,838,680 individuals, without prior mycobacterial disease, who participated in the 2009 National Health Screening Exam. We evaluated the incidence of mycobacterial disease (tuberculosis or nontuberculous mycobacterial infection) in participants with allergic disease (asthma, allergic rhinitis, or atopic dermatitis) and those without allergic disease. We followed the cohort up until the date of mycobacterial disease diagnosis, follow-up loss, death, or December 2018.
During a median follow-up of 8.3 (interquartile range, 8.1-8.6) years, 0.6% of participants developed mycobacterial disease. The incidence of mycobacterial disease was significantly higher in those with allergic diseases than in those without allergic diseases (1.0 vs 0.7/1000 person-years; P < .001), with an adjusted hazard ratio of 1.13 (95% CI, 1.10-1.17). Asthma (adjusted hazard ratio, 1.37; 95% CI, 1.29-1.45) and allergic rhinitis (adjusted hazard ratio, 1.07; 95% CI, 1.04-1.11) increased the hazard of mycobacterial disease, whereas atopic dermatitis did not. The association between allergic diseases and hazard of mycobacterial disease was more prominent in older (age ≥ 65 years, P for interaction = .012) and obese (body mass index ≥ 25 kg/m, P for interaction < .001) participants.
Allergic diseases including asthma and allergic rhinitis were associated with an increased risk of mycobacterial disease, whereas atopic dermatitis was not.
过敏性疾病与分枝杆菌病的风险之间的关联尚不清楚。
评估过敏性疾病与分枝杆菌病之间的关联。
这是一项基于人群的队列研究,共纳入 3838680 名无既往分枝杆菌病且参加了 2009 年国家健康筛查检查的个体。我们评估了患有过敏性疾病(哮喘、过敏性鼻炎或特应性皮炎)和无过敏性疾病的参与者中分枝杆菌病(结核病或非结核分枝杆菌感染)的发病率。我们对队列进行了随访,直至发生分枝杆菌病、随访丢失、死亡或 2018 年 12 月。
在中位数为 8.3 年(四分位距,8.1-8.6 年)的随访期间,0.6%的参与者发生了分枝杆菌病。与无过敏性疾病的参与者相比,患有过敏性疾病的参与者发生分枝杆菌病的风险显著更高(1.0 比 0.7/1000 人年;P<0.001),调整后的危险比为 1.13(95%CI,1.10-1.17)。哮喘(调整后的危险比,1.37;95%CI,1.29-1.45)和过敏性鼻炎(调整后的危险比,1.07;95%CI,1.04-1.11)增加了分枝杆菌病的发病风险,而特应性皮炎则没有。过敏性疾病与分枝杆菌病发病风险之间的关联在年龄较大(≥65 岁,交互作用 P 值=0.012)和肥胖(体重指数≥25 kg/m,交互作用 P 值<0.001)的参与者中更为显著。
包括哮喘和过敏性鼻炎在内的过敏性疾病与分枝杆菌病的风险增加相关,而特应性皮炎则没有。